[ABCL] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
30-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 4,444.60%
YoY- 7,229.80%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 5,508 27,643 202,741 207,908 9,362 11,228 4,657 11.82%
PBT -24,972 -2,073 161,487 155,915 -2,693 6,703 -2,093 421.35%
Tax -3,592 250 44,266 39 0 0 0 -
NP -21,380 -2,323 117,221 117,000 -2,693 6,703 -2,093 370.12%
Tax Rate - - -27.41% -0.02% - 0.00% - -
Total Cost 26,888 29,966 85,520 90,909 12,055 4,525 6,750 151.07%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -388.16 -8.40 57.82 56.27 -28.77 59.70 -44.94 320.41%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.08 -0.01 0.43 0.43 -0.01 0.03 -0.01 299.49%
EPS Diluted -0.08 -0.01 0.37 0.37 -0.01 0.03 -0.01 299.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.